The Story Of Our Firm | En Español
 Home    Lawyers   Litigation   Choose Us   Settlements   Search

Previous Investigations Other Litigations Celebrex Research Center

How It Works

in this section: How It Works | Celebrex and Vioxx | Side Effects | Celebrex History | Press Release | Market Names for Bextra, Vioxx & Celebrex | Dosage | Back Pain


Bookmark This Page Print This Page Email This Page

Basic Celebrex Information

Like Vioxx, Celebrex, manufactured by Pfizer Pharmaceuticals in 1998, belongs to a family of painkillers referred to as Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). NSAIDs are intended to reduce swelling and inflammation, and are frequently taken to treat several types of arthritis, menstrual discomfort, and other kinds of pain.

Along with other NSAIDs, such as Bextra and Vioxx, Celebrex was prescribed as a substitute to other pain medications because they were thought to have fewer gastrointestinal side effects than conventional drugs.

Non-steroidal anti-inflammatory drugs (NSAIDs) are prescribed to patients who suffer from arthritis and pain where the major adverse side effect from taking these medicines is gastrointestinal toxicity.

NSAIDs works by blocking both COX-1 enzymes (produces prostaglandins that maintain a homeostatic environment in the stomach, kidney, GI tract and causes platelet coagulation and endothelial constriction) and COX-2 enzymes (produces prostaglandins that create pain, inflammation, dilates endothelial tissues, and acts as a natural anti-coagulant).

The inhibitory effect on each type of enzyme depends upon the unique chemical constitution of each NSAID. The most common adverse effect from these non-selective NSAIDs occurs within a patient’s gastrointestinal tract.

Celebrex is a part of a new class of NSAIDs, the COX-2 selective drugs. Selective COX-2 drugs, also including Bextra and Vioxx were created to decrease stomach, kidney and gastrointestinal problems by only inhibiting the cyclooxygenase enzyme that is explicitly responsible for inflammation and pain unlike traditional NSAIDs that targeted all COX enzymes that included COX-1 (that creates prostaglandins that help the stomach, kidneys, and GI tract). Nonetheless, inhibiting only COX-2 enzymes creates an imbalance that leads to increased adverse cardiovascular events.

Although COX-2 enzymes are commonly recognized for their symptoms of inflammation and pain, they aid in the maintenance of healthy platelet activity that decreases the risk for adverse cardiovascular events such as heart attacks and strokes. Patients may be exchanging GI risks for cardiovascular risks when switching traditional NSAIDs for COX-2 selective drugs, because inhibiting mostly COX-2 enzymes creates a higher level of COX-1 enzymes that are known for promoting vasoconstriction and platelet aggregation.

Although each COX-2 selective drug has a slightly different composition, they virtually have similar side effects those of which include increased cardiovascular risk, gastrointestinal events, and in patients.

If you believe that you or a loved one has been affected by Celebrex, fill out the form below for a free case evaluation.

Weitz & Luxenberg is no longer accepting Celebrex cases.


see also:

How It Works Celebrex: It May Be Causing You Serious Health Problems!
Celebrex May Be Causing You Serious Health Problems

Side Effects Celebrex Side Effects - Learn about Dangerous Side Effects of Celebrex
Celebrex Side Effects: Heart Attack, Stroke, Heart Disease and More

Learn More Read more about heart problems due to Celebrex
Celebrex can lead to serious heart problems - Learn about them here

Free Legal Review:
Name:
Phone:
Email:
Case Description:



For legal help anywhere in the U.S.
Ask a Free Question:
Were you injured?

check for your response [login]
$53 million verdict — brake mechanic suffering from mesothelioma

$13.5 million verdict — one of the very first Vioxx trial cases

$15 million settlement — man wound up a paraplegic due to negligent hospital care

$37 million verdict — 2 asbestos lung cancer plaintiffs

$47 million verdict — boilermaker who died from mesothelioma

$2.6 million settlement — ill-fitting prosthesis caused decubitus ulcers

$75 million verdict — historic consolidated trial involving men who had worked at the Brooklyn Navy Yard in the 1940s and 1950s

$12.7 million verdict — iron worker who was injured due to unsafe working conditions

$8 million settlement — obstetrical malpractice resulted in neurological deficits

$64.65 million award — 4 asbestos plaintiffs

$17.5 million — consolidated trial of 5 mesothelioma victims